Methods of determining SAM-dependent methyltransferase activity using a mutant SAH hydrolase

• US 6,610,504 B1
• Filed: 04/10/2000
• Issued: 08/26/2003
• Est. Priority Date: 04/10/2000
• Status: Expired due to Fees

• Current Assignee: General Atomics, Inc.
• Original Assignee: General Atomics, Inc.
• Inventors: Yuan, Chong-Sheng
• Primary Examiner(s): Prouty, Rebecca E.
• Assistant Examiner(s): Steadman, David J.
• Application Number:
  US09/546,013
• Time in Patent Office: 1,233 Days
• Field of Search: 435/15, 435/18
• US Class Current: 506/11
• CPC Class Codes: C12Q 1/34 involving hydrolase
• CPC Class Codes: C12Q 1/48 involving transferase

Abstract

The present invention relates to compositions and methods for assaying the activity of methyltransferases, such as S-adenosylmethionine (SAM)-dependent methyltransferases. The methods can be used for screening for modulators of such methyltransferases, for identifying substrates and for diagnostics. The methods are amenable for use in high throughput formats. Kits for performing the methods are also provided.

Claims

1. A method for assaying for the activity of a S-adenosylmethionine (SAM)-dependent methyltransferase, comprising:

a) contacting a SAM-dependent methyltransferase with a substrate of the methyltransferase in the presence of SAM, whereby a methyl group is transferred from the methyltransferase to the substrate and the SAM is converted into S-adenosylhomocysteine (SAH);

b) contacting the resulting SAH with a mutant SAH hydrolase which substantially retains its binding affinity or has enhanced binding affinity for SAH but has attenuated catalytic activity; and

c) detecting binding between the SAH and the mutant SAH hydrolase to detect or determine the presence or amount of the SAH, whereby the activity of the SAM-dependent methyltransferase is assessed.

2. The method of claim 1, wherein the SAM-dependent methyltransferase is selected from the group consisting of a protein methyltransferase, a nucleic acid methyltransferase, a lipid methyltransferase, a polysaccharide methyltransferase and a small molecule methyltransferase.

3. The method of claim 2, wherein the nucleic acid methyltransferase is a DNA methyltransferase or a RNA methyltransferase.

4. The method of claim 1, wherein the SAM-dependant methyltransferase comprises an amino acid consensus sequence selected from the group consisting of motif I ((V/I/L)(L/V)(D/E)(V/I)G(G/C)G(T/P)G), motif II ((P/G)(Q/T)(F/Y/A)DA(I/V/Y)(F/I)(C/V/L)) and motif III (LL(R/K)PGG(R/I/L)(L/I)(L/F/I/V)(I/L) of combinations thereof.

5. The method of claim 4, wherein the SAM-dependent methyltransferase comprises all the motifs I, II and III in the order of N′

-I-II-III-C′

, the distance between the last amino acid residue of motif I and the first amino acid residue of motif II is from about 36 to about 90 amino acid residues, and the distance between the last amino acid residue of motif II and the first amino acid residue of motif III is from about 12 to about 38 amino acid residues.

6. The method of claim 4, wherein the SAM-dependent methyltransferase comprises the motif I only or comprises the motifs I and III only.

7. The method of claim 1, wherein the method for assaying for the activity of the methyltransferase is a diagnostic assay.

8. The method of claim 1, wherein the method for assaying for the activity of the methyltransferase is an assay for screening for compounds that modulate the activity of the methyltransferase.

9. The method of claim 1, further comprising comparing the activity of the methyltransferase to a control, whereby a change in the activity is detected.

10. The method of claim 1, wherein the mutant SAH hydrolase has attenuated hydrolytic activity but substantially retains its oxidative activity when compared to a wildtype SAH hydrolase from which the mutant SAH hydrolase is derived.

11. The method of claim 1, wherein the SAH is contacted with the mutant SAH hydrolase in the presence of a labeled SAH or a derivative or an analog thereof, whereby the amount of the labeled SAH bound to the mutant SAH hydrolase inversely relates to amount of the SAH produced in step a).

12. The method of claim 11, wherein the labeled SAH derivative or analog is fluorescenctly labeled.

13. The method of claim 1, wherein the mutant SAH hydrolase is a labeled mutant SAH hydrolase.

14. The method of claim 1, wherein the activities of a plurality of SAM-dependant methyltransferases are assayed simultaneously.

15. The method of claim 1, wherein the mutant SAH hydrolase is linked to a solid support.

16. The method of claim 15, wherein a plurality of SAH hydrolases are linked to the support.

17. The method of claim 16, wherein the mutant SAH hydrolases are arranged in an array on the solid support.